Supplement To Earnings News Release - 4Q13

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2013.
               
Fourth   Fourth   Year Ended   Year Ended
Quarter Quarter Dec. 31, Dec. 31,
$ in millions, except EPS amounts   2013   2012   2013   2012
Sales   $11,319   $11,738   $44,033   $47,267
GAAP EPS   0.26   0.30   1.47   2.00

Non-GAAP EPS that excludes items listed below 1
  0.88   0.83   3.49   3.82

GAAP Net Income 2
  781   908   4,404   6,168

Non-GAAP Net Income that excludes items listed below 1,2
  2,599   2,540   10,443   11,743

Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88 and $3.49 for the full year of 2013 exclude acquisition-related costs, restructuring costs and certain other items.

If you liked this article you might like

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Why You Keep Cash on Hand; No Downside Conviction -- Jim Cramer's Top Thoughts